Essentials for Clinicians: Gynaecological Tumours - Editors and Contributors

Editors

  • Andreas du Bois,Arbeitsgemeinschaft Gynaekologische Onkologie Study Group Kliniken Essen-Mitte, Department of Gynaecology and Gynaecologic Oncology, Essen, Germany
  • Marcia Hall, Mount Vernon Cancer Centre Northwood, UK
  • Christina C Fotopoulou, Ovarian Cancer Action Research Centre Department of Surgery and Cancer Imperial College London, UK 

Series editor: Michele Ghielmini, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland

Contributors

Chapter 1 - Histopathology of gynaecological cancers 

  • GD Aletti - Department of Gynaecologic Oncology, European Institute of Oncology, Milan, Italy
  • S Carinelli - Department of Pathology, European Institute of Oncology, Milan, Italy 

Chapter 2 - Staging and surgical treatment of ovarian cancer 

  • S Mahner - Department of Gynecology and Obstetrics, University of Munich, Munich, Germany 
  • L Woelber - University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany 

Chapter 3 - Systemic treatment of ovarian cancer 

  • D Krell - Mount Vernon Cancer Centre, Northwood, UK 
  • M Hall - Mount Vernon Cancer Centre, Northwood, UK

Chapter 4 - Staging and surgical treatment of endometrial cancer 

  • MJ Halaska - Gynecologic Oncology Center, Department of Obstetrics and Gynecology, University Hospital Kralovske Vinohrady, Third Medical Faculty, Charles University, Prague, Czech Republic 
  • L Rob - Gynecologic Oncology Center, Department of Obstetrics and Gynecology, University Hospital Kralovske Vinohrady, Third Medical Faculty, Charles University, Prague, Czech Republic 

Chapter 5 - Non-surgical treatment of endometrial cancer 

  • M Mirza - Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark 

Chapter 6 - Staging and surgical treatment of cervical cancer 

  • D Cibula - Gynecologic Oncology Center, Department of Obstetrics and Gynecology, Charles University in Prague and General University Hospital in Prague, Czech Republic 

Chapter 7 - Non-surgical treatment of cervical cancer 

  • S Marnitz - Department of Radiation Oncology, Charité University Medicine, Berlin, Germany 

CC Fotopoulou - Department of Gynecological Oncology, Imperial College London, London, UK 

Chapter 8 - Epidemiology and risk factors for ovarian, uterine and cervical cancers 

  • A Gonzalez Martin - MD Anderson Cancer Center, Madrid, Spain 

Chapter 9 - Diagnosis and treatment of vulvar cancer 

  • L Rob - Gynecologic Oncology Center, Department of Obstetrics and Gynecology, University Hospital Kralovske Vinohrady, Third Medical Faculty, Charles University, Prague, Czech Republic 
  • P Skapa - Department of Pathology and Molecular Biology, Second Medical Faculty, Charles University, Prague, Czech Republic 

Chapter 10 - Rare gynaecological cancers 

  • I Ray-Coquard - Medical Oncology, Centre Léon Bérard, Lyon, France 
  • H Vanacker - Medical Oncology, Centre Léon Bérard, Lyon, France 

Chapter 11 - Hereditary ovarian and uterine cancer syndromes 

  • C Marth - Department of Obstetrics and Gynecology, Medical University, Innsbruck, Austria 

Chapter 12 - New drugs and novel treatment strategies for gynaecological cancers 

  • M Zweifel - Department of Medical Oncology, University Hospital Bern, Switzerland 
  • C Sessa - Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland 

Declarations of interest

  • GD Aletti: No conflicts of interest.
  • S Carinelli: No conflicts of interest.
  • D Cibula: No conflicts of interest.
  • CC Fotopoulou: No conflicts of interest.
  • A Gonzalez Martin: No conflicts of interest.
  • MJ Halaska: No conflicts of interest.
  • M Hall: Advisory Boards for GlaxoSmithKline, Roche, AstraZeneca, Merck.
  • D Krell: No conflicts of interest.
  • S Mahner: No conflicts of interest.
  • S Marnitz: No conflicts of interest. 
  • C Marth: No conflicts of interest.
  • M Mirza: No conflicts of interest.
  • I Ray-Coquard: No conflicts of interest.
  • L Rob: No conflicts of interest.
  • C Sessa: No conflicts of interest.
  • P Skapa: No conflicts of interest.
  • H Vanacker: No conflicts of interest.
  • L Woelber: No conflicts of interest.
  • M Zweifel: Advisory role for Roche. 
Chapter 1 - Histopathology of Gynaecological Cancers

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings